PT1335930E - Processo para a preparacao de 3-oxo-4-aza-esteroides - Google Patents

Processo para a preparacao de 3-oxo-4-aza-esteroides

Info

Publication number
PT1335930E
PT1335930E PT01988307T PT01988307T PT1335930E PT 1335930 E PT1335930 E PT 1335930E PT 01988307 T PT01988307 T PT 01988307T PT 01988307 T PT01988307 T PT 01988307T PT 1335930 E PT1335930 E PT 1335930E
Authority
PT
Portugal
Prior art keywords
oxo
preparation
aza
steroids
compounds
Prior art date
Application number
PT01988307T
Other languages
English (en)
Inventor
Alan Millar
Davis Roman
Sterbenz Jeffrey Thomas
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT1335930E publication Critical patent/PT1335930E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Valve Device For Special Equipments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT01988307T 2000-11-03 2001-11-02 Processo para a preparacao de 3-oxo-4-aza-esteroides PT1335930E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0026876.3A GB0026876D0 (en) 2000-11-03 2000-11-03 Process

Publications (1)

Publication Number Publication Date
PT1335930E true PT1335930E (pt) 2005-01-31

Family

ID=9902484

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01988307T PT1335930E (pt) 2000-11-03 2001-11-02 Processo para a preparacao de 3-oxo-4-aza-esteroides

Country Status (24)

Country Link
US (1) US6794508B2 (pt)
EP (1) EP1335930B1 (pt)
JP (1) JP4257117B2 (pt)
KR (1) KR100821018B1 (pt)
CN (1) CN1313480C (pt)
AT (1) ATE279429T1 (pt)
AU (2) AU2002241624B2 (pt)
BR (1) BR0115089A (pt)
CA (1) CA2427709A1 (pt)
DE (1) DE60106482T2 (pt)
DK (1) DK1335930T3 (pt)
ES (1) ES2230383T3 (pt)
GB (1) GB0026876D0 (pt)
HK (1) HK1058799A1 (pt)
HU (1) HUP0303907A3 (pt)
IL (2) IL155078A0 (pt)
MX (1) MXPA03003925A (pt)
NO (1) NO325180B1 (pt)
NZ (1) NZ525168A (pt)
PL (1) PL206539B1 (pt)
PT (1) PT1335930E (pt)
SI (1) SI1335930T1 (pt)
WO (1) WO2002046207A2 (pt)
ZA (1) ZA200302560B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503193B1 (ko) 2002-08-19 2005-07-25 한미약품 주식회사 3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법
WO2005075497A1 (en) * 2004-01-07 2005-08-18 Ranbaxy Laboratories Limited PROCESS FOR THE PREPARATION OF 17ß-SUBSTITUTED-3-OXO-4-AZA-5ALPHA-ANDROSTANE DERIVATIVES
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法
AR070313A1 (es) * 2008-01-03 2010-03-31 Gador Sa Un procedimiento para preparar una forma solida y cristalina de dutasteride, una forma polimorfica del compuesto (forma iii) y una composicion farmaceutica que incluye dicha forma
HU230730B1 (hu) 2011-06-30 2017-12-28 Richter Gedeon Nyrt Eljárás (5alfa,17béta)-N-[2,5-bisz-(trifluormetil)-fenil]-3-oxo-4-aza-5-androszt-1-én-17-karbonsavamid előállítására
CN103059097A (zh) * 2011-10-20 2013-04-24 连云港润众制药有限公司 一种度他雄胺中间体的制备方法
CN103254268A (zh) * 2013-05-16 2013-08-21 寿光市富康化学工业有限公司 一种制备度他雄胺的工艺
CN104231033B (zh) * 2014-09-17 2016-08-24 广东众生药业股份有限公司 一种度他雄胺的制备方法
CN108051513B (zh) * 2017-11-27 2020-09-29 重庆华邦制药有限公司 Hplc法分离测定度他雄胺起始原料sm2及其相关杂质的方法
CN109438549B (zh) * 2018-12-13 2022-01-04 湖北葛店人福药业有限责任公司 一种制备N-叔丁基-3-氧代-4-氮杂-5α-雄甾-17β-甲酰胺的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211145A (en) 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB2264494A (en) 1992-02-25 1993-09-01 Merck & Co Inc 17b-n-monosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-1-en-3-one testosterone-5-alpha reductase inhibitors
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones

Also Published As

Publication number Publication date
WO2002046207A3 (en) 2003-03-20
KR100821018B1 (ko) 2008-04-08
WO2002046207A2 (en) 2002-06-13
JP4257117B2 (ja) 2009-04-22
ATE279429T1 (de) 2004-10-15
KR20030081326A (ko) 2003-10-17
DE60106482T2 (de) 2005-10-13
NO20031995D0 (no) 2003-05-02
HK1058799A1 (en) 2004-06-04
EP1335930A2 (en) 2003-08-20
PL206539B1 (pl) 2010-08-31
IL155078A0 (en) 2003-10-31
PL365705A1 (en) 2005-01-10
CN1473165A (zh) 2004-02-04
AU4162402A (en) 2002-06-18
ES2230383T3 (es) 2005-05-01
US6794508B2 (en) 2004-09-21
HUP0303907A3 (en) 2012-09-28
NO20031995L (no) 2003-05-02
BR0115089A (pt) 2003-10-07
EP1335930B1 (en) 2004-10-13
AU2002241624B2 (en) 2004-10-28
NZ525168A (en) 2005-03-24
IL155078A (en) 2009-06-15
HUP0303907A2 (hu) 2004-03-01
CN1313480C (zh) 2007-05-02
NO325180B1 (no) 2008-02-11
US20040049042A1 (en) 2004-03-11
SI1335930T1 (en) 2005-04-30
ZA200302560B (en) 2004-04-01
GB0026876D0 (en) 2000-12-20
MXPA03003925A (es) 2003-08-19
DK1335930T3 (da) 2005-02-14
CA2427709A1 (en) 2002-06-13
DE60106482D1 (de) 2004-11-18
JP2004515505A (ja) 2004-05-27

Similar Documents

Publication Publication Date Title
BR0113670A (pt) Composição farmacêutica e método para tratar hipogonadismo
BR0317091A (pt) Processo para preparação de 1-olefinas através da dissociação catalìtica de 1-alcoxialcanos
PT1335930E (pt) Processo para a preparacao de 3-oxo-4-aza-esteroides
ATE255589T1 (de) Kristallin form i von clarithromycin
PT971705E (pt) Formulacoes de farmacos de terapeutica de substituicao hormonal para aplicacao topica na pele
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
HUP9901679A2 (hu) Eljárás influenzavírus kimutatására és az eljárásban alkalmazható vegyületek
PT1282663E (pt) Gel constituido por um poli-alfa-1,4-glucano e amido
DK1171101T3 (da) Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix
AR023700A1 (es) Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
BR0308466A (pt) Processo para preparar eplerenona
EE05318B1 (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hpogonadismi raviks
BR0115359A (pt) Método para a preparação de uma composição catalisadora e seu uso em um processo de polimerização
ES2147446T3 (es) Procedimiento de adicion de oro en dos etapas para preparar un catalizador del acetato de vinilo.
PT1102765E (pt) Processo para a sintese de derivados de (1h)-benzo¬c|quinolizin-3-onas
AU2001231849A1 (en) Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin
BR0115416A (pt) Método para a preparação de uma composição catalisadora e seu uso em um processo de polimerização
BRPI0017522B8 (pt) processo para preparação de secretagogos de hormônio de crescimento e polimorfo
BR0314624A (pt) Revestimento, processo de preparação e uso deste em suporte de madeira
WO2001097792A3 (en) Neuraminidase inhibitors in the treatment of equine influenza virus infection
ES2193398T3 (es) Esteres eritro-3-amino-2-hidroxibutiricos opticamente activos y procedimiento para preparar dichos esteres.
PT937094E (pt) Processo para a preparacao de ivermectina
ES2220440T3 (es) Composicion disolvente medioambientalmente segura.
BRPI0402077A (pt) Nanocápsulas contendo princìpios ativos lipofìlicos, uso de nanocápsulas, composições farmacêuticas e processo de preparação de nanocápsulas
ECSP003326A (es) 1,2,3,4,5,6 - hexahidro- 2,6 - metano - 3 - benzazocin - 10 - oles sustituidos con n- (5- fenil- tetahidrofuranil) metilo y n-(6-feniltetrahidropiranil) metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas